{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:28:15Z","timestamp":1793978895911,"version":"4.8.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["2025-358"],"award-info":[{"award-number":["2025-358"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007334","name":"Ministry of Health and Family Welfare","doi-asserted-by":"publisher","award":["RS-2025-25452008"],"award-info":[{"award-number":["RS-2025-25452008"]}],"id":[{"id":"10.13039\/501100007334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["RS-2024-00441954"],"award-info":[{"award-number":["RS-2024-00441954"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008783","name":"National Research Council of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008783","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003052","name":"Ministry of Trade, Industry and Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022930","name":"Korea Foundation for Women In Science, Engineering and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022930","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004080","name":"Korea Drug Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004080","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejmech.2026.119269","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:33:00Z","timestamp":1787920380000},"page":"119269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Discovery of novel pyrazolo[3,4-d]pyrimidine-6-amine derivatives as potent polo-like kinase 2 inhibitors"],"prefix":"10.1016","volume":"319","author":[{"given":"Seoyeong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Hyun","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soomin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang-Gon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sieun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghwa","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwan Won","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongkyun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misook","family":"Ham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyoung","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung In","family":"Pyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Kyoung","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyebin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeongmin","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaehoon","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinha","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan Seong","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiman","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5812-3826","authenticated-orcid":false,"given":"Seo-Jung","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119269_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101174","article-title":"Global colorectal cancer burden in 2020 and projections to 2040","volume":"14","author":"Xi","year":"2021","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.ejmech.2026.119269_bib2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41392-020-0116-z","article-title":"Comprehensive review of targeted therapy for colorectal cancer","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ejmech.2026.119269_bib3","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.5306\/wjco.v15.i9.1136","article-title":"Colorectal cancer: recent advances in management and treatment","volume":"15","author":"Fadlallah","year":"2024","journal-title":"World J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2026.119269_bib4","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/s13046-021-02130-2","article-title":"Resistance to anti-EGFR therapies in metastatic colorectal cancer: underlying mechanisms and reversal strategies","volume":"40","author":"Zhou","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2026.119269_bib5","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.tips.2023.01.003","article-title":"Metastatic colorectal cancer: mechanisms and emerging therapeutics","volume":"44","author":"Shin","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2026.119269_bib6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/imm.13785","article-title":"A new strategy for immunotherapy of microsatellite-stable (MSS)-type advanced colorectal cancer: multi-pathway combination therapy with PD-1\/PD-L1 inhibitors","volume":"173","author":"Cai","year":"2021","journal-title":"Immunol. Ser."},{"key":"10.1016\/j.ejmech.2026.119269_bib7","doi-asserted-by":"crossref","first-page":"e580","DOI":"10.1093\/oncolo\/oyae013","article-title":"The efficacy of immune checkpoint inhibitors in microsatellite stable colorectal cancer: a systematic review","volume":"29","author":"Guven","year":"2024","journal-title":"Oncol"},{"key":"10.1016\/j.ejmech.2026.119269_bib8","article-title":"Polo-like kinase 2: from principle to practice","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejmech.2026.119269_bib9","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.cub.2004.06.059","article-title":"Polo-like kinase-2 is required for centriole duplication in mammalian cells","volume":"14","author":"Warnke","year":"2004","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ejmech.2026.119269_bib10","first-page":"1401","article-title":"Polo-like kinase 2 promotes chemoresistance and predicts limited survival benefit from adjuvant chemotherapy in colorectal cancer","volume":"52","author":"Xie","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejmech.2026.119269_bib11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.canlet.2016.07.004","article-title":"Plk2 promotes tumor growth and inhibits apoptosis by targeting Fbxw7\/Cyclin E in colorectal cancer","volume":"380","author":"Ou","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2026.119269_bib12","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/cmdc.201300166","article-title":"Selective and brain\u2010permeable polo\u2010like Kinase\u20102 (Plk\u20102) inhibitors that reduce \u03b1\u2010Synuclein phosphorylation in Rat brain","volume":"8","author":"Aubele","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2026.119269_bib13","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1158\/1078-0432.CCR-08-2445","article-title":"BI 6727, a Polo-like kinase inhibitor with improved pharmacokinetic profile and broad antitumor activity","volume":"15","author":"Rudolph","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2026.119269_bib14","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.ejmech.2017.11.058","article-title":"Design, synthesis, and biological evaluation of novel highly selective polo-like kinase 2 inhibitors based on the tetrahydropteridin chemical scaffold","volume":"143","author":"Zhan","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119269_bib15","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.bmc.2015.11.045","article-title":"Discovery of 2-(1H-indol-5-ylamino)-6-(2, 4-difluorophenylsulfonyl)-8-methylpyrido [2, 3-d] pyrimidin-7 (8H)-one (7ao) as a potent selective inhibitor of polo like kinase 2 (PLK2)","volume":"24","author":"Reddy","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119269_bib16","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1016\/j.bmcl.2004.06.029","article-title":"Synthesis and biological evaluation of pteridine and pyrazolopyrimidine based adenosine kinase inhibitors","volume":"14","author":"Gomtsyan","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119269_bib17","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1021\/acs.jmedchem.5b00140","article-title":"Studies on the ATP binding site of Fyn kinase for the identification of new inhibitors and their evaluation as potential agents against tauopathies and tumors","volume":"58","author":"Tintori","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119269_bib18","series-title":"5-Pyridinone Substituted","author":"Guzzo","year":"2008"},{"key":"10.1016\/j.ejmech.2026.119269_bib19","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1016\/j.tetlet.2010.06.020","article-title":"One-pot sulfide to sulfone oxidation with m-Chloroperoxybenzoic acid and sodium permanganate","volume":"51","author":"Dishington","year":"2010","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2026.119269_bib20","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1021\/co200039k","article-title":"Microwave-assisted, divergent solution-phase synthesis of 1,3,6-Trisubstituted Pyrazolo[3,4-d]pyrimidines","volume":"13","author":"Liu","year":"2011","journal-title":"ACS Comb. Sci."},{"key":"10.1016\/j.ejmech.2026.119269_bib21","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1158\/1535-7163.MCT-12-0907","article-title":"Tandutinib inhibits the Akt\/mTOR signaling pathway to inhibit colon cancer growth","volume":"12","author":"Ponnurangam","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ejmech.2026.119269_bib22","doi-asserted-by":"crossref","first-page":"314","DOI":"10.5599\/admet.4.4.341","article-title":"Preclinical formulation for the pharmacokinetics and efficacy of GBO-006, a selective polo-like kinase 2 (PLK2) inhibitor for the treatment of triple negative breast cancer","volume":"4","author":"Maddi","year":"2016","journal-title":"ADMET & DMPK"},{"key":"10.1016\/j.ejmech.2026.119269_bib23","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3892\/ijo.2023.5542","article-title":"DYRK1A-Mediated PLK2 phosphorylation regulates the proliferation and invasion of glioblastoma cells","volume":"63","author":"Tan","year":"2023","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejmech.2026.119269_bib24","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2026.119269_bib25","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/jcc.540150503","article-title":"ICM\u2014A new method for protein modeling and design: applications to docking and structure prediction from the distorted native conformation","volume":"15","author":"Abagyan","year":"1994","journal-title":"J. Comput. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426007142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426007142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:04:46Z","timestamp":1793977486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426007142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":25,"alternative-id":["S0223523426007142"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119269","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel pyrazolo[3,4-d]pyrimidine-6-amine derivatives as potent polo-like kinase 2 inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119269","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119269"}}